Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-8.14%
operating margin TTM
-2174.0%
revenue TTM
20.25 Million
revenue per share TTM
2.25$
valuation ratios | |
|---|---|
| pe ratio | -22.79 |
| peg ratio | -0.53 |
| price to book ratio | 1.86 |
| price to sales ratio | 1.86 |
| enterprise value multiple | -0.07 |
| price fair value | 1.86 |
profitability ratios | |
|---|---|
| gross profit margin | 29.98% |
| operating profit margin | -2174.0% |
| pretax profit margin | -8.1% |
| net profit margin | -8.14% |
| return on assets | -4.78% |
| return on equity | -8.55% |
| return on capital employed | -1415.54% |
liquidity ratio | |
|---|---|
| current ratio | 3.41 |
| quick ratio | 1.80 |
| cash ratio | 0.85 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 139.94 |
| operating cycle | 192.45 |
| days of payables outstanding | 18.57 |
| cash conversion cycle | 173.89 |
| receivables turnover | 6.95 |
| payables turnover | 19.66 |
| inventory turnover | 2.61 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.33 |
| debt equity ratio | 0.57 |
| long term debt to capitalization | 0.26 |
| total debt to capitalization | 0.36 |
| interest coverage | -1,052.72 |
| cash flow to debt ratio | 0.02 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.01 |
| cash per share | 0.43 |
| operating cash flow per share | 0.04 |
| free cash flow operating cash flow ratio | -0.30 |
| cash flow coverage ratios | 0.02 |
| short term coverage ratios | 0.24 |
| capital expenditure coverage ratio | 0.77 |
Frequently Asked Questions
When was the last time ImmuCell Corporation (NASDAQ:ICCC) reported earnings?
ImmuCell Corporation (ICCC) published its most recent earnings results on 13-11-2024.
What is ImmuCell Corporation's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. ImmuCell Corporation (NASDAQ:ICCC)'s trailing twelve months ROE is -8.55%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. ImmuCell Corporation (ICCC) currently has a ROA of -4.78%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ICCC's net profit margin stand at?
ICCC reported a profit margin of -8.14% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ICCC's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.41 in the most recent quarter. The quick ratio stood at 1.80, with a Debt/Eq ratio of 0.57.